Skip to menu Skip to content Skip to footer
Professor Carmel Hawley
Professor

Carmel Hawley

Email: 
Phone: 
+61 7 3176 2625

Overview

Background

Carmel Hawley MBBS, FRACP, M.Med.Sci, is a Senior Staff Specialist and Director of Haemodialysis Services at Princess Alexandra Hospital. In addition, she is an Associate Professor (A/P) of Medicine at the School of Medicine, University of Queensland and current (inaugural) Chair for the Australasian Kidney Trials network (AKTN) formed in 2005. Under A/P Hawley’s stewardship, AKTN’s research output is now recognised internationally for its quality and impact. This has driven major advances in the evidence base, that directly informs care and outcomes for people living with chronic kidney disease. A/P Hawley also holds a Master’s degree in Biostatistics, has expertise in trial management, methodology, design and conduct. She is currently involved in numerous industry-led and/or investigator initiated international and national clinical trials as either a Principal or Associate Investigator, providing leadership and direction to emerging early and mid-career researchers.

Availability

Professor Carmel Hawley is:
Available for supervision
Media expert

Fields of research

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Masters (Coursework), Institution to be confirmed
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Research interests

  • Chronic Kidney Disease

  • Kidney Transplant

  • Kidney Dialysis

  • Kidney Clinical Trials

Works

Search Professor Carmel Hawley’s works on UQ eSpace

715 works between 1965 and 2025

601 - 620 of 715 works

2005

Journal Article

Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients?

Armstrong, Kirsten A., Johnson, David W., Campbell, Scott B., Isbel, Nicole M. and Hawley, Carmel M. (2005). Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients?. Transplantation, 80 (11), 1565-1571. doi: 10.1097/01.tp.0000183895.88572.13

Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients?

2005

Journal Article

Obesity is Associated with Worsening Cardiovascular Risk Factor Profiles and Proteinuria Progression in Renal Transplant Recipients

Armstrong, Kirsten A., Campbell, Scott B., Hawley, Carmel M., Nicol, David L., Johnson, David W. and Isbel, Nicole M. (2005). Obesity is Associated with Worsening Cardiovascular Risk Factor Profiles and Proteinuria Progression in Renal Transplant Recipients. American Journal of Transplantation, 5 (11), 2710-2718. doi: 10.1111/j.1600-6143.2005.01073.x

Obesity is Associated with Worsening Cardiovascular Risk Factor Profiles and Proteinuria Progression in Renal Transplant Recipients

2005

Journal Article

Free Fatty Acids Are Associated with Obesity, Insulin Resistance, and Atherosclerosis in Renal Transplant Recipients

Armstrong, Kirsten A., Hiremagalur, Balaji, Haluska, Brian A., Campbell, Scott B., Hawley, Carmel M., Marks, Lisa, Prins, Johannes, Johnson, David W. and Isbel, Nicole M. (2005). Free Fatty Acids Are Associated with Obesity, Insulin Resistance, and Atherosclerosis in Renal Transplant Recipients. Transplantation, 80 (7), 937-944. doi: 10.1097/01.tp.0000173792.53561.b6

Free Fatty Acids Are Associated with Obesity, Insulin Resistance, and Atherosclerosis in Renal Transplant Recipients

2005

Conference Publication

Does uric acid have a pathogenetic role in hypertension and kidney disease in renal transplant recipients?

Armstrong, K., Campbell, S., Johnson, D., Hawley, C. and Isbel, N. (2005). Does uric acid have a pathogenetic role in hypertension and kidney disease in renal transplant recipients?. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, ACT, Australia, 11-13 May 2005. Oxford, United Kingdom: John Wiley & Sons.

Does uric acid have a pathogenetic role in hypertension and kidney disease in renal transplant recipients?

2005

Conference Publication

Body mass index predicts the progression of proteinuria in renal transplant recipients

Armstrong, K., Campbell, S., Hawley, C., Hiremagalur, B., Nicol, D., Johnson, D. and Isbel, N. (2005). Body mass index predicts the progression of proteinuria in renal transplant recipients. 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Canberra, ACT, Australia, 11-13 May 2005. Oxford, United Kingdom: John Wiley & Sons.

Body mass index predicts the progression of proteinuria in renal transplant recipients

2005

Journal Article

Elevated white cell count at commencement of peritoneal dialysis predicts overall and cardiac mortality

Johnson, David Wayne, Wiggins, Kathryn Joan, Armstrong, Kirsten Anne, Campbell, Scott Bryan, Isbel, Nicole Maree and Hawley, Carmel Mary (2005). Elevated white cell count at commencement of peritoneal dialysis predicts overall and cardiac mortality. Kidney International, 67 (2), 738-743. doi: 10.1111/j.1523-1755.2005.67135.x

Elevated white cell count at commencement of peritoneal dialysis predicts overall and cardiac mortality

2005

Journal Article

Generalized, pruritic, ulcerating maculopapular rash necessitating cessation of sirolimus in a liver transplantation patient

Tracey, Christopher, Hawley, Carmel, Griffin, Anthony Donald, Strutton, Geoff and Lynch, Stephen (2005). Generalized, pruritic, ulcerating maculopapular rash necessitating cessation of sirolimus in a liver transplantation patient. Liver Transplantation, 11 (8), 987-989. doi: 10.1002/lt.20499

Generalized, pruritic, ulcerating maculopapular rash necessitating cessation of sirolimus in a liver transplantation patient

2005

Journal Article

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

Mudge, David W., Rogers, Robyn, Hollett, Peter, Law, Belinda, Reiger, Kylie, Petrie, James J. B., Price, Lee, Johnson, David W., Campbell, Scott B., Isbel, Nicole M., Sullivan, Matthew and Hawley, Carmel M. (2005). Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance. Nephrology Dialysis Transplantation, 20 (10), 2178-2185. doi: 10.1093/ndt/gfh987

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

2005

Conference Publication

Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients

Armstrong, K., Elliott, A. M., Prins, J., Beller, E., Campbell, Scott B., Hawley, C., Johnson, David W. and Isbel, N. (2005). Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients. 6th American Transplant Congress, Seattle, WA, U.S.A., 21-25 May 2005. Oxford, U.K.: Blackwell Publishing. doi: 10.1111/j.1600-6135.2005.abstracts.x

Fasting blood glucose is an unreliable screening tool for predicting impaired glucose tolerance in renal transplant recipients

2005

Conference Publication

Measurement of insulin resistance is not necessary for the identification of the metabolic syndrome in renal transplant recipients

Armstrong, K., Hiremagalur, B., Campbell, S., Hawley, C., Johnson, D., Prins, J. and Isbel, N. (2005). Measurement of insulin resistance is not necessary for the identification of the metabolic syndrome in renal transplant recipients. 23rd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, The Australian Academy of Science, Canberra ACT, Australia, 11 - 13 May, 2005. Basingstoke, U.K.: Nature Publishing Group. doi: 10.1111/j.1440-1711.2005.0000.x

Measurement of insulin resistance is not necessary for the identification of the metabolic syndrome in renal transplant recipients

2005

Journal Article

Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor)

Mudge, David W., Johnson, David W., Isbel, Nicole M., Campbell, Scott B., Nicol, David L. and Hawley, Carmel M. (2005). Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor). Nephrology Dialysis Transplantation, 20 (1), 246-247. doi: 10.1093/ndt/gfh580

Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor)

2005

Journal Article

Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: A follow-up study after revascularization

Hanekom, Lizelle, Jenkins, Carly, Jeffriess, Leanne, Case, Colin, Mundy, Julie, Hawley, Carmel and Marwick, Thomas H. (2005). Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: A follow-up study after revascularization. Circulation, 112 (25), 3892-3900. doi: 10.1161/CIRCULATIONAHA.104.489310

Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: A follow-up study after revascularization

2005

Conference Publication

Markers of oxidative stress predict cardiac outcomes in patients with CKD

Wong, J., Coombes, J. S., Trobel, N. A., Hawley, C., Campbell, S., Johnson, D. and Isbel, N. M. (2005). Markers of oxidative stress predict cardiac outcomes in patients with CKD. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3–7 September, 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Markers of oxidative stress predict cardiac outcomes in patients with CKD

2005

Journal Article

Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients

Fryer, Anthony A., Ramsay, Helen M., Lovatt, Tracy J., Jones, Peter W., Hawley, Carmel M., Nicol, David L., Strange, Richard C. and Harden, Paul N. (2005). Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients. Carcinogenesis, 26 (1), 185-191. doi: 10.1093/carcin/bgh291

Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients

2005

Journal Article

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

Atcheson, Bronwyn A., Taylor, Paul J., Mudge, David W., Johnson, David W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Pillans, Peter I. and Tett, Susan E. (2005). Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. British Journal of Clinical Pharmacology, 59 (3), 271-280. doi: 10.1111/j.1365-2125.2004.02235.x

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

2005

Journal Article

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients

Johnson, David Wayne, van Eps, Carolyn, Mudge, David William, Wiggins, Kathryn Joan, Armstrong, Kirsty, Hawley, Carmel Mary, Campbell, Scott Bryan, Isbel, Nicole Maree, Nimmo, Graeme Robert and Gibbs, Harry (2005). Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients. Journal of The American Society of Nephrology, 16 (5), 1456-1462. doi: 10.1681/ASN.2004110997

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients

2005

Conference Publication

Clinical variables add incremental value to fasting blood glucose in predicting a positive glucose tolerance test in established renal transplant recipients

Armstrong, Kirsten, Elliott, Anne Maree, Prins, Johannes, Beller, Elaine, Campbell, Scott B., Hawley, Carmel, Johnson, David W. and Isbel, Nicole (2005). Clinical variables add incremental value to fasting blood glucose in predicting a positive glucose tolerance test in established renal transplant recipients. 6th American Transplant Congress, Seattle, WA, USA, 21-25 May, 2005. Oxford, England: Blackwell Publishing. doi: 10.1111/j.1600-6135.2005.abstracts.x

Clinical variables add incremental value to fasting blood glucose in predicting a positive glucose tolerance test in established renal transplant recipients

2005

Conference Publication

Does uric acid have a pathogenetic role in hypertension and graft dysfunction in renal transplant recipients?

Hawley, C., Armstrong, K., Johnson, D., Campbell, S. and Isbel, N. (2005). Does uric acid have a pathogenetic role in hypertension and graft dysfunction in renal transplant recipients?. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x

Does uric acid have a pathogenetic role in hypertension and graft dysfunction in renal transplant recipients?

2005

Journal Article

Impact of obesity on renal transplant outcomes

Armstrong, Kirsten A., Campbell, Scott B., Hawley, Carmel M., Johnson, David W. and Isbel, Nicole M. (2005). Impact of obesity on renal transplant outcomes. Nephrology, 10 (4), 405-413. doi: 10.1111/j.1440-1797.2005.00406.x

Impact of obesity on renal transplant outcomes

2004

Journal Article

Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders

Sturtevant, Joanna M., Hawley, Carmel M., Reiger, Kylie, Johnson, David W., Campbell, Scott B., Burke, John R., Bofinger, Andrew and Isbel, Nicole M. (2004). Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders. Nephrology, 9 (6), 406-413. doi: 10.1111/j.1440-1797.2004.00338.x

Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders

Funding

Current funding

  • 2024 - 2029
    A multi-centre randomised controlled trial to treat acute T-cell mediated rejection in kidney and kidney pancreas transplant recipients (TACKLE-IT trial) (USyd administered MRFF ICTC 2023 grant)
    University of Sydney
    Open grant
  • 2024 - 2029
    A randomised trial of intensive vs less intensive corticosteroids for children with nephrotic syndrome (OPEN trial) (Administered by Flinders University)
    Flinders University
    Open grant
  • 2021 - 2026
    Centre of Research Excellence: Partnering with patients with chronic kidney disease to transform care and outcomes (CRE-PACT) (administered by University of Sydney)
    University of Sydney
    Open grant
  • 2021 - 2027
    An adaptive, randomised controlled trial to treat polyomavirus infections (BKPyV) in kidney and kidney pancreas transplant recipients (BEAT-BK) trial (MRFF RCRDUN led by USyd)
    University of Sydney
    Open grant
  • 2020 - 2025
    Serum phosphate to improve outcomes for dialysis patients: The PHOSPHATE Trial (HRC New Zealand)
    University of Otago
    Open grant
  • 2020 - 2025
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC CTCS administered by USYD)
    University of Sydney
    Open grant
  • 2019 - 2025
    Better health through better trials: A national network to develop and implement innovative clinical trials methodology (NHMRC CRE administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2021 - 2023
    Patient perspectives and involvement in co-design of a trial evaluating interventions to improve gut health in peritoneal dialysis - GUT PD Study (ISPD grant led by Eastern Institute of Technology)
    Eastern Institute of Technology
    Open grant
  • 2021 - 2024
    Better Evidence and Translation In Chronic Kidney Disease (BEAT-CKD) (administered by SAHMRI)
    South Australian Health and Medical Research Institute Limited
    Open grant
  • 2020 - 2024
    BEAT-Calci (Better Evidence And Translation in Calciphylaxis) (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2020 - 2024
    Vascular Access outcome measure for function: a vaLidation study In haemoDialysis (VALID)
    Metro South Hospital and Health Service
    Open grant
  • 2019 - 2024
    NAVKIDS2 trial: a multi-centre, dynamic, waitlist randomized controlled trial of patient navigators in children with chronic kidney disease (MRFF RCRDUN administered by University of Sydney)
    University of Sydney
    Open grant
  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2020
    IMPEDE-PKD (Implementation of Metformin therapy to Ease Decline of kidney function in PKD). A Clinical Trial Investigating Metformin to slow the progression of renal dysfunction in ADPKD
    PKD Foundation of Australia Limited
    Open grant
  • 2018 - 2024
    Better Evidence for Selecting Transplant Fluids: The BEST-Fluids Trial (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2017 - 2022
    Evaluation of the efficacy and safety of health service dialysate sodium practice on clinical outcomes (NHMRC Project Grant externally led by the University of Sydney)
    University of New South Wales
    Open grant
  • 2016 - 2021
    Mid Cut-Off Haemodialysis: a safety and efficacy study
    Baxter Healthcare Pty Ltd
    Open grant
  • 2016
    The BLOCADE Study
    Austin Medical Research Foundation
    Open grant
  • 2016 - 2019
    Pexivas - NIHR
    Cambridge University Hospitals NHS Foundation Trust
    Open grant
  • 2016
    The TECH-PD trial (pilot study)
    International Society of Peritoneal Dialysis
    Open grant
  • 2016 - 2021
    Better evidence, better care and outcomes for people with chronic kidney disease (NHMRC Program Grant administered by Flinders University)
    Flinders University
    Open grant
  • 2014 - 2019
    KHA Operations Support
    Kidney Health Australia
    Open grant
  • 2014 - 2017
    ANZSN Operations Support
    Australian and New Zealand Society of Nephrology
    Open grant
  • 2013 - 2018
    A randomised, double-blind, placebo-controlled trial to assess the effect of phosphate reduction with lanthanum carbonate on arterial compliance and vascular calcification in patients with chronic kid
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    FAVOURED Trial
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2013
    IMPROVE: IMPROVE (IMpact of Phospate Reduction on Vascular Endpoints in Chronic Kidney Disease)
    PA Research Foundation
    Open grant
  • 2012 - 2013
    The utility of matrix metalloproteinase-2 (MMP-2) to predict peritoneal injury in the incident PD population
    Kidney Health Australia
    Open grant
  • 2012 - 2014
    Serial NT-proBNP Monitoring for Predicting Major Cardiovascular Events in the Dialysis Population
    NHMRC Project Grant
    Open grant
  • 2011 - 2013
    AVATAR: ACE Inhibition for the preservation of renal function and patient survival in kidney transplantation (Canadian Institutes of Health Research grant admin. by the Ottawa Hospital Research Inst.)
    Ottawa Hospital Research Institute
    Open grant
  • 2011 - 2015
    The Beta-blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study (NHMRC Project Grant administered by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2011 - 2012
    The Utility of Serial NT-proBNP Monitoring for Predicting Cardiac Outcomes in the Dialysis Population
    Kidney Health Australia
    Open grant
  • 2010 - 2017
    PEXIVAS: Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (NHMRC Project Grant administered by the University of Adelaide)
    Central Adelaide Local Health Network Incorporated, trading as Royal Adelaide Hospital
    Open grant
  • 2010 - 2016
    Favoured: fish oil and aspirin in vascular access outcomes in renal disease
    Abbott Products Operations AG
    Open grant
  • 2010 - 2020
    IMPROVE: IMpact of Phosphate Reduction On Vascular Endpoints in chronic kidney disease
    Shire
    Open grant
  • 2008 - 2013
    A randomised controlled trial of exit site application of Medihoney(TM) for the prevention of catheter associated infections in peritoneal dialysis patients
    Queensland Health Smart Health Research Grant
    Open grant
  • 2008 - 2011
    A randomised, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia
    AMGEN Australia Pty. Ltd.
    Open grant
  • 2007 - 2010
    HERO (A randomized, placebo-controlled trial of oxpentifylline on haemoglobin levels in patients with erythropoietin-resistant anaemia)
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant
  • 2007 - 2014
    A trial of aspirin and fish oil for the prevention of thrombosis in dialysis access
    University of Western Australia
    Open grant
  • 2005 - 2016
    Australasian Kidney Trials Network (AKTN)
    NHMRC Enabling Grant
    Open grant
  • 2005 - 2011
    Australasian Clinical Trials Network in Nephrology (CTNN)
    Australian Kidney Foundation
    Open grant
  • 2005 - 2011
    Australialian Kidney Trials (AKT) Network
    Australian and New Zealand Society of Nephrology
    Open grant

Supervision

Availability

Professor Carmel Hawley is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Professor Carmel Hawley directly for media enquiries about:

  • Chronic Kidney Disease
  • Haemodialysis
  • Kidney Clinical Trials
  • Kidney Dialysis
  • Kidney Transplant
  • Nephrology
  • Peritoneal Dialysis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au